H.J. Teede, C.T. Tay, J.J.E. Laven et al., Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Eur. J. Endocrinol. 189(2), G43–G64 (2023). https://doi.org/10.1093/ejendo/lvad096

Article  PubMed  Google Scholar 

G. Bozdag, S. Mumusoglu, D. Zengin, E. Karabulut, B.O. Yildiz, The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum. Reprod. 31(12), 2841–2855 (2016). https://doi.org/10.1093/humrep/dew218

Article  PubMed  Google Scholar 

Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil. Steril. 81(1), 19–25 (2004). https://doi.org/10.1016/j.fertnstert.2003.10.004

Article  Google Scholar 

R.S. Legro, S.A. Arslanian, D.A. Ehrmann et al., Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 98(12), 4565–4592 (2013). https://doi.org/10.1210/jc.2013-2350.

Article  CAS  PubMed  PubMed Central  Google Scholar 

L.G. Cooney, A. Dokras, Cardiometabolic risk in polycystic ovary syndrome: current guidelines. Endocrinol. Metab. Clin. North Am. 50(1), 83–95 (2021). https://doi.org/10.1016/j.ecl.2020.11.001

Article  PubMed  Google Scholar 

C. Zhuang, X. Luo, W. Wang, R. Sun, M. Qi, J. Yu, Corrigendum: cardiovascular risk according to body mass index in reproductive-aged women with polycystic ovary syndrome: a systematic review and meta-analysis. Front. Cardiovasc. Med. 10, 1186990 (2023). https://doi.org/10.3389/fcvm.2023.1186990.

Article  PubMed  PubMed Central  Google Scholar 

M.M. Ollila, A. Hoek, T.T. Piltonen, The association between polycystic ovary syndrome and early cardiovascular disease morbidity strengthens. Eur. J. Endocrinol. 189(1), R4–R5 (2023). https://doi.org/10.1093/ejendo/lvad083

Article  PubMed  Google Scholar 

M. Forslund, J. Melin, S. Alesi et al., Different kinds of oral contraceptive pills in polycystic ovary syndrome: a systematic review and meta-analysis. Eur. J. Endocrinol. 189(1), S1–S16 (2023). https://doi.org/10.1093/ejendo/lvad082

Article  PubMed  Google Scholar 

H.J. Teede, M.L. Misso, M.F. Costello et al., Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Clin. Endocrinol. 89(3), 251–268 (2018). https://doi.org/10.1111/cen.13795

Article  Google Scholar 

M. Wang, B.Q. Zhang, S. Ma, Y. Xu, D.H. Zhao, J.S. Zhang, C.J. Li, X. Zhou, L.W. Zheng, Broadening horizons: the role of ferroptosis in polycystic ovary syndrome. Front. Endocrinol. 15, 1390013 (2024). https://doi.org/10.3389/fendo.2024.1390013. Aug 2PMID: 39157678; PMCID: PMC11327064

Article  Google Scholar 

M. Mathew, S. Sivaprakasam, J.L. Phy, Y.D. Bhutia, V. Ganapathy, Polycystic ovary syndrome and iron overload: biochemical link and underlying mechanisms with potential novel therapeutic avenues. Biosci. Rep. 43(1), BSR20212234 (2023). https://doi.org/10.1042/BSR20212234.

Article  CAS  PubMed  PubMed Central  Google Scholar 

K. Roemhild, F. von Maltzahn, R. Weiskirchen, R. Knüchel, S. von Stillfried, T. Lammers, Iron metabolism: pathophysiology and pharmacology. Trends Pharmacol. Sci. 42(8), 640–656 (2021). https://doi.org/10.1016/j.tips.2021.05.001.

Article  CAS  PubMed  PubMed Central  Google Scholar 

J. Montonen, H. Boeing, A. Steffen et al., Body iron stores and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study. Diabetologia 55(10), 2613–2621 (2012). https://doi.org/10.1007/s00125-012-2633-y.

Article  CAS  PubMed  PubMed Central  Google Scholar 

J.D. Cook, C.H. Flowers, B.S. Skikne, The quantitative assessment of body iron. Blood 101(9), 3359–3364 (2003). https://doi.org/10.1182/blood-2002-10-3071

Article  CAS  PubMed  Google Scholar 

J.W. Kim, K.M. Kang, T.K. Yoon, S.H. Shim, W.S. Lee, Study of circulating hepcidin in association with iron excess, metabolic syndrome, and BMP-6 expression in granulosa cells in women with polycystic ovary syndrome. Fertil. Steril. 102(2), 548–554.e2 (2014). https://doi.org/10.1016/j.fertnstert.2014.04.031

Article  CAS  PubMed  Google Scholar 

H.F. Escobar-Morreale, M. Luque-Ramírez, F. Alvarez-Blasco, J.I. Botella-Carretero, J. Sancho, J.L. San Millán, Body iron stores are increased in overweight and obese women with polycystic ovary syndrome. Diabetes Care 28(8), 2042–2044 (2005). https://doi.org/10.2337/diacare.28.8.2042

Article  PubMed  Google Scholar 

M. Luque-Ramírez, F. Alvarez-Blasco, J.I. Botella-Carretero, R. Sanchón, J.L. San Millán, H.F. Escobar-Morreale, Increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism and are not a result of reduced menstrual losses. Diabetes Care 30(9), 2309–2313 (2007). https://doi.org/10.2337/dc07-0642

Article  CAS  PubMed  Google Scholar 

S. Behboudi-Gandevani, H. Abtahi, N. Saadat, M. Tohidi, F. Ramezani Tehrani, Effect of phlebotomy versus oral contraceptives containing cyproterone acetate on the clinical and biochemical parameters in women with polycystic ovary syndrome: a randomized controlled trial. J. Ovarian Res. 12(1), 78 (2019). https://doi.org/10.1186/s13048-019-0554-9. Published 2019 Aug 30

Article  CAS  PubMed  PubMed Central  Google Scholar 

M. Luque-Ramírez, A.E. Ortiz-Flores, M.Á. Martínez-García et al., Effect of iron depletion by bloodletting vs. observation on oxidative stress biomarkers of women with functional hyperandrogenism taking a combined oral contraceptive: a randomized clinical trial. J. Clin. Med. 11(13), 3864 (2022). https://doi.org/10.3390/jcm11133864.

Article  CAS  PubMed  PubMed Central  Google Scholar 

J.H. Yang, C.H. Chou, W.S. Yang, H.N. Ho, Y.S. Yang, M.J. Chen, Iron stores and obesity are negatively associated with ovarian volume and anti-Müllerian hormone levels in women with polycystic ovary syndrome. Taiwan J. Obstet. Gynecol. 54(6), 686–692 (2015). https://doi.org/10.1016/j.tjog.2014.11.025

Article  PubMed  Google Scholar 

S. Bekri, P. Gual, R. Anty et al., Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology 131(3), 788–796 (2006). https://doi.org/10.1053/j.gastro.2006.07.007

Article  CAS  PubMed  Google Scholar 

E. Nemeth, S. Rivera, V. Gabayan et al., IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J. Clin. Investig. 113(9), 1271–1276 (2004). https://doi.org/10.1172/JCI20945

Article  CAS  PubMed  PubMed Central  Google Scholar 

L.M. Tussing-Humphreys, E. Nemeth, G. Fantuzzi et al., Elevated systemic hepcidin and iron depletion in obese premenopausal females. Obesity 18(7), 1449–1456 (2010). https://doi.org/10.1038/oby.2009.319

Article  CAS  PubMed  Google Scholar 

F. Moro, A. Morciano, A. Tropea et al., Effects of drospirenone-ethinylestradiol and/or metformin on CD4(+)CD28(null) T lymphocytes frequency in women with hyperinsulinemia having polycystic ovary syndrome: a randomized clinical trial. Reprod. Sci. 20(12), 1508–1517 (2013). https://doi.org/10.1177/1933719113488444

Article  CAS  PubMed  Google Scholar 

N. Cinar, A. Harmanci, M. Bayraktar, B.O. Yildiz, Ethinyl estradiol-drospirenone vs ethinyl estradiol-drospirenone plus metformin in the treatment of lean women with polycystic ovary syndrome. Clin. Endocrinol. 78(3), 379–384 (2013). https://doi.org/10.1111/j.1365-2265.2012.04415

Article  CAS  Google Scholar 

A. Harmanci, N. Cinar, M. Bayraktar, B.O. Yildiz, Oral contraceptive plus antiandrogen therapy and cardiometabolic risk in polycystic ovary syndrome. Clin. Endocrinol. 78(1), 120–125 (2013). https://doi.org/10.1111/j.1365-2265.2012.04466.x

Article  CAS  Google Scholar 

S. Shahani, M. Braga-Basaria, M. Maggio, S. Basaria, Androgens and erythropoiesis: past and present. J. Endocrinol. Investig. 32(8), 704–716 (2009). https://doi.org/10.1007/BF03345745

Article  CAS  Google Scholar 

H.F. Escobar-Morreale, M. Luque-Ramírez, Role of androgen-mediated enhancement of erythropoiesis in the increased body iron stores of patients with polycystic ovary syndrome. Fertil. Steril. 95(5), 1730–5.e1 (2011). https://doi.org/10.1016/j.fertnstert.2011.01.038

Article  CAS  PubMed